ABT vs TBBK · P/E 25, rev $44.33B vs P/E 11, rev $261.8M
Abbott Laboratories (ABT) versus The Bancorp Inc (TBBK) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
The Bancorp Inc (TBBK) is a banks - regional company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported TBBK revenue for 2026-06-30 was $261.8M. Net income was $120.7M. TBBK currently screens at market cap $2.30B and trailing P/E 10.8.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. TBBK currently screens at market cap $2.30B and trailing P/E 10.8.
Not investment advice. Open the ABT and TBBK stock pages for the full models.
Not investment advice.